BHB
ORGS

Bank Hapoalim BM’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bank Hapoalim BM’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,205
Closed -$19K – 140
2024
Q2 		$19K Hold
3,205
– – ﹤0.01% 136
2024
Q1 		$26K Hold
3,205
– – ﹤0.01% 136
2023
Q4 		$16K Hold
3,205
– – ﹤0.01% 143
2023
Q3 		$20K Hold
3,205
– – ﹤0.01% 132
2023
Q2 		$45K Hold
3,205
– – 0.01% 150
2023
Q1 		$38K Hold
3,205
– – 0.01% 156
2022
Q4 		$63K Hold
3,205
– – 0.01% 158
2022
Q3 		$46K Hold
3,205
– – 0.01% 162
2022
Q2 		$78K Hold
3,205
– – 0.01% 172
2022
Q1 		$111K Hold
3,205
– – 0.01% 194
2021
Q4 		$92K Buy
+3,205
New +$125K 0.01% 241

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank Hapoalim BM's ORGS Position: Q3 2024 in Review

Bank Hapoalim BM sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2024, closing a stake of 3,205 shares — an estimated $19K sold.

Bank Hapoalim BM first reported a position in ORGS in Q4 2021 and held it in 11 quarters. The position peaked at $111K in Q1 2022. 11 funds tracked by Wall St. Rank hold ORGS as of Q3 2024.

  • Bank Hapoalim BM reported no remaining Orgenesis Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Bank Hapoalim BM sold 3,205 Orgenesis Inc. Common Stock shares in Q3 2024, an estimated $19K.
  • Bank Hapoalim BM first reported a position in Orgenesis Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Bank Hapoalim BM's Orgenesis Inc. Common Stock position peaked at $111K in Q1 2022.
  • 11 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2024.

Based on Bank Hapoalim BM's 13F filing for Q3 2024, filed 28 Oct 2024.